Pacific Biosciences of California, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 48.7% | -78.5% | -82.0% |
| FY2017 | 37.1% | -96.1% | -98.6% |
| FY2018 | 31.9% | -128.4% | -130.4% |
| FY2019 | 38.0% | -110.6% | -92.6% |
| FY2020 | 41.3% | -132.3% | 37.3% |
| FY2021 | 45.1% | -161.2% | -138.9% |
| FY2022 | 38.2% | -239.4% | -244.9% |
| FY2023 | 26.3% | -166.8% | -153.0% |
| FY2024 | 24.2% | -308.0% | -201.2% |
| FY2025 | 28.6% | -346.2% | -341.5% |